MITBX
Price
$35.50
Change
-$0.21 (-0.59%)
Updated
Jul 13 closing price
Net Assets
6.94B
VFFSX
Price
$367.80
Change
-$2.94 (-0.79%)
Updated
Jul 13 closing price
Net Assets
1.67T
Interact to see
Advertisement

MITBX vs VFFSX

MITBX vs VFFSX Comparison Chart in %
View a ticker or compare two or three
VS
MITBX vs. VFFSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MITBX is a StrongBuy and VFFSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.67T vs. MITBX (6.94B). VFFSX pays higher dividends than MITBX: VFFSX (1.08) vs MITBX (0.02). MITBX was incepted earlier than VFFSX: MITBX (33 years) vs VFFSX (10 years). MITBX (1.44) is less costly to investors than VFFSX (0.01). MITBX is a more actively managed with annual turnover of: 26.00 vs. VFFSX (2.00). MITBX has a lower initial minimum investment than VFFSX: MITBX (1000) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 21.07 vs. MITBX (0.11). VFFSX return over 5 years is better than : 73.48 vs. MITBX (-11.08).
MITBXVFFSXMITBX / VFFSX
Total Expense Ratio1.440.0114,400%
Annual Report Gross Expense Ratio1.440.0114,400%
Fund Existence33 years10 years-
Gain YTD8.37610.68578%
Front LoadN/AN/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.94B1.67T0%
Annual Yield % from dividends0.021.082%
Returns for 1 year0.1121.071%
Returns for 3 years4.5668.457%
Returns for 5 years-11.0873.48-15%
Returns for 10 years30.11251.2112%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZIEX20.58N/A
N/A
Lazard International Equity Instl
CMNWX91.13N/A
N/A
Principal Capital Appreciation A
PRWCX38.43N/A
N/A
T. Rowe Price Capital Appreciation
TRZYX24.28N/A
N/A
T. Rowe Price Latin America Z
MCYSX16.25-0.50
-2.99%
NYLI Candriam Emerging Markets Eq Cl R6